Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease)
Country | Agency | Year work was carried out | Link | Details of use |
|---|---|---|---|---|
Austria | LBI-HTA | 2019 | – | National Adaptation. Added executive summary in German. |
Austria | GOEG | 2019 | – | Dissemination. Forwarder the report to the responsible persons in our MoH. |
Croatia | AAZ | 2019 | – | Dissemination – Prepared the summary and assessment elements B0001 and A0020 in Croatian (will be published on the AAZ website along with links to the full EUnetHTA assessment). |
Italy | AGENAS | 2019 | LINK | Translation of the report summary. |
Norway | NIPHNO | Ongoing | – | Dissemination – Informed the National Commission Forum for Introduction of New Technologies into the Norwegian Specialist Health Care about the assessment. |
Romania | NSPHMPDB | 2019 | – | Dissemination – Letter to the MoH. Link on the NSPHMPDB Facebook page. |
Slovakia | UNIBA | 2019 | – | National adaptation. Updated evidence. Added impact / cost-effectiveness analysis. |
Spain | SCS | 2019 | – | Dissemination – seminars and courses. |
Sweden | SBU | 2019 | – | Dissemination. |
United Kingdom (England) | NICE | 2019 | LINK | Dissemination – incorporated into NHS Evidence as a source of information for clinicians. |
United Kingdom (Scotland) | SHTG | 2019 | – | Dissemination to clinical directorate to assess level of interest in this technology in Scotland. |
United Kingdom (Wales) | HTW | Ongoing | – | Shared with national Welsh procurement committee considering stent use. Use of HTA to be determined. |
